- Report
- March 2024
- 191 Pages
Global
From €3274EUR$3,374USD£2,823GBP
€3638EUR$3,749USD£3,137GBP
- Report
- January 2024
- 200 Pages
Global
From €4852EUR$5,000USD£4,184GBP
- Report
- April 2024
- 93 Pages
Global
From €5434EUR$5,600USD£4,686GBP
- Report
- February 2024
- 190 Pages
Global
From €3493EUR$3,600USD£3,012GBP
- Report
- October 2019
- 125 Pages
Global
From €4803EUR$4,950USD£4,142GBP
- Report
- February 2024
- 132 Pages
Global
From €922EUR$950USD£795GBP
The Electronic Drug Delivery System (EDDS) market is a subset of the larger drug delivery market. EDDS is a technology-driven system that enables the delivery of drugs to patients in a safe and efficient manner. It is used to monitor and control the delivery of drugs, as well as to provide real-time data on drug usage. EDDS can be used to deliver drugs to patients in a variety of settings, including hospitals, clinics, and home care.
EDDS can be used to improve patient safety and reduce the risk of medication errors. It can also help to reduce the cost of drug delivery, as well as improve the accuracy and speed of drug delivery. EDDS can also be used to monitor drug usage and provide real-time data on drug usage.
Some companies in the EDDS market include Becton Dickinson, Baxter International, and Novo Nordisk. Other companies include Merck, Pfizer, and Sanofi. Show Less Read more